Featured
LP.png
Longitude Prize Workshop
AACC.png
3i Diagnostics has emerged from 'stealth mode' and have presented details of our technology to the public
NSF.png
3i Diagnostics Awarded Competitive Grant from the National Science Foundation Small Business Innovation Research Program Provides Seed Funding for R&D
CEO-CFO.png
CEO CFO Magazine Interview
FDA.png
3iDx received Breakthrough Device Designation from FDA
NPRLogo_RGB.png
A Superbug That Resisted 26 Antibiotics
ext.jpeg
3iDx voted The Buzz of BIO for the 2017 BIO Investor Forum
Surviving-Sepis.png
2016 Surviving Sepsis Campaign Guidelines
PBSNewshour.png
We are Running Out of Effective Antibiotics Fast
BHL.png
BioHealth Innovation: Local Startup Developing Technology for Real-Time Detection of Bacteria
Nature.png
Antibiotic Resistance: The Last Resort
BBC.png
How Can we Stop Antibiotic Resistance?
NPRLogo_RGB.png
Are State Rules For Treating Sepsis Really Saving Lives?
DukeToday.png
Researchers Identify Biomarker that Predicts Death in Sepsis Patients
GenomeWeb.png
Genome Web: Startup 3iDx Raising $5M for Infrared-Based Pathogen ID Platform
WorldHealth.png
Tackling Antimicrobial Drug Resistance
PMC.png
The Antibiotic Resistance Crisis
WhiteHouse.png
PCAST Releases New Report on Combating Antibiotic Resistance
Harvard.png
Superbug: An Epidemic Begins
CDC.png
Latest Report from the CDC: Antibiotic Resistance Threats in the United States
Frontline.png
Hunting The Nightmare Bacteria

 

SOLUTIONS > CLINICAL IMPACT > CONTACT >

3i DIAGNOSTICS, INC., 20271 GOLDENROD LANE V5, GERMANTOWN, MD 20876

© 2026 3i Diagnostics, Inc. — Germantown, MD. All rights reserved. | FDA Breakthrough Device | NSF SBIR Recipient